Also known as: Intas Pharmaceuticals
Intas Pharmaceuticals is an Indian multinational pharmaceutical company with integrated capabilities in development, manufacturing, and marketing of formulations. The company reports broad international operations through subsidiaries including Accord Healthcare and presence across many countries. It was founded in 1977 and is headquartered in Ahmedabad, India.
Bio-Thera Solutions expands its partnership with Intas Pharmaceuticals for BAT2506, a golimumab biosimilar, through an exclusive commercialization agreement for India. The India biosimilars market is projected to grow from $184 million to $1.02 billion by 2035, driven by patent expirations and strategic partnerships.
Swiss pharmaceutical major Novartis AG has signed a definitive agreement to sell its entire 70.68% stake in Novartis India to a ChrysCapital-led consortium for Rs 1,446 crore, with a mandatory open offer for an additional 26% from public shareholders.
